FDA InspectionSolara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited – FDA Inspection, Jul 27, 2018
Record Details
This FDA Inspection record concerns Solara Active Pharma Sciences Limited, with an inspection on July 27, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
ID · 80cb8a9a-7283-4409-ad89-16216e7940e6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1063623
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Solara Active Pharma Sciences Limited
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 29, 2025 | Not classified | Office of Inspections and Investigations | |
| February 21, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 3, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 7, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Or discuss it with
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every Solara Active Pharma Sciences Limited document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA